A novel component of the metabolic syndrome: the oxidative stress
- PMID: 19747805
- DOI: 10.1016/j.numecd.2009.06.002
A novel component of the metabolic syndrome: the oxidative stress
Abstract
The metabolic syndrome (MS) represents a cluster of cardiovascular (CV) risk factors associated to CV disease and type 2 diabetes. It is still under debate whether MS is a mere aggregation of risk factors or it represents a clinical entity with visceral obesity as underlying pathophysiological trigger. The publication of several diagnostic criteria of MS by scientific associations or experts panels reflects this uncertainty in understanding the real nature of MS. Besides the metabolic disturbances of MS, as visceral obesity, hypertriglyceridemia, low HDL cholesterol, hypertension and hyperglycemia, novel mechanisms of arterial damage have been identified. This paper reviews the evidence showing that MS and MS factors are characterized by increased oxidative stress, a relevant factor contributing to the development of metabolic and cardiovascular complications. In the next future, the measure of plasma oxidative stress may contribute to identify a subset of MS patients at increased CV risk, candidates to more intensive therapies.
Copyright 2009 Elsevier B.V. All rights reserved.
Similar articles
-
Metabolic syndrome.J Insur Med. 2004;36(2):132-42. J Insur Med. 2004. PMID: 15301226 Review.
-
Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.Minerva Cardioangiol. 2006 Apr;54(2):195-214. Minerva Cardioangiol. 2006. PMID: 16778752 Review.
-
Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.Am J Cardiol. 2008 Dec 22;102(12A):5L-9L. doi: 10.1016/j.amjcard.2008.09.067. Am J Cardiol. 2008. PMID: 19084083 Review.
-
The metabolic syndrome and its cardiovascular manifestations.Bol Asoc Med P R. 2005 Oct-Dec;97(4):271-80. Bol Asoc Med P R. 2005. PMID: 16599068 Review.
-
Metabolic syndrome.Minerva Med. 2006 Jun;97(3):219-29. Minerva Med. 2006. PMID: 16855517 Review.
Cited by
-
Overview of Ethnobotanical-Pharmacological Studies Carried Out on Medicinal Plants from the Serra da Estrela Natural Park: Focus on Their Antidiabetic Potential.Pharmaceutics. 2024 Mar 25;16(4):454. doi: 10.3390/pharmaceutics16040454. Pharmaceutics. 2024. PMID: 38675115 Free PMC article. Review.
-
Circulating Fatty Acids Associate with Metabolic Changes in Adolescents Living with Obesity.Biomedicines. 2024 Apr 17;12(4):883. doi: 10.3390/biomedicines12040883. Biomedicines. 2024. PMID: 38672237 Free PMC article.
-
Role of apigenin in targeting metabolic syndrome: A systematic review.Iran J Basic Med Sci. 2024;27(5):524-534. doi: 10.22038/IJBMS.2024.71539.15558. Iran J Basic Med Sci. 2024. PMID: 38629096 Free PMC article. Review.
-
Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review).Mol Med Rep. 2024 Jun;29(6):95. doi: 10.3892/mmr.2024.13219. Epub 2024 Apr 12. Mol Med Rep. 2024. PMID: 38606791 Free PMC article. Review.
-
Elemental iron protects gut microbiota against oxygen-induced dysbiosis.PLoS One. 2024 Feb 27;19(2):e0298592. doi: 10.1371/journal.pone.0298592. eCollection 2024. PLoS One. 2024. PMID: 38412144 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical